Nov 18, 2025 02:04AM Evercore ISI Starts Upstream Bio (UPB) at Outperform

Nov 5, 2025 07:39AM UpstreamBio (UPB) files mixed shelf

Oct 20, 2025 08:23AM Piper Sandler Sees 'Significant Upside Opportunity' for Upstream Bio (UPB)

Oct 17, 2025 08:32AM Truist Securities: 'Is Biotech Back?!'

Oct 14, 2025 06:06AM Truist Securities Starts Upstream Bio (UPB) at Buy

Sep 30, 2025 05:01AM Upstream Bio presents verekitug mechanism data at respiratory conference

Aug 26, 2025 08:08AM Piper Sandler on Upstream Bio (UPB): 'We Remain Bullish on Verekitug's Commercial Potential'

Jul 28, 2025 07:28AM JPMorgan Reiterates Overweight Rating on Upstream Bio (UPB)

Jul 8, 2025 07:07AM Upstream Bio (UPB) doses first patient in COPD trial for verekitug

May 20, 2025 07:01AM Upstream Bio (UPB) Appoints Stacy Price as Chief Technology Officer

Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies

Nov 5, 2024 05:30AM TD Cowen Starts Upstream Bio (UPB) at Buy

Nov 5, 2024 03:46AM Piper Sandler Starts Upstream Bio (UPB) at Overweight

Nov 5, 2024 03:03AM JPMorgan Starts Upstream Bio (UPB) at Overweight

Oct 11, 2024 12:43PM Upstream Bio (UPB) Opens At $21.50, IPO Priced At $17

Oct 11, 2024 06:02AM Upstream Bio (UPB) Prices Upsized 15M Share IPO at $17/sh

Oct 7, 2024 06:15AM Upstream Bio (UPB) Files for 12.5M Share IPO at $15-$17/sh

Sep 18, 2024 04:09PM Upstream Bio (UPB) Files for Proposed IPO